The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics.
The firm's has expanded its ctDNA sequencing test to cover 17 genes, enough to provide a readout of microsatellite instability for guiding cancer immunotherapy use.
PacBio is looking to increase the yield and reduce the cost of the protocol, which enables long reads and accurate sequencing.
New funding will support assay development and lab space to offer test services, and ultimately a test kit using the firm's resistance database.
Following FDA approval last October, Adaptive has now secured Medicare coverage for its NGS-based minimal residual disease assay, ClonoSeq.
Fabric Genomics is providing Diagnomics with clinical decision support technology to help healthcare providers understand variants in the ACMG-59 panel.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.
This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.